captopril has been researched along with Uremia in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (57.89) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fiedler, R; Girndt, M; Seibert, E; Trojanowicz, B; Ulrich, C | 1 |
Aladjem, M; Averbukh, Z; Berman, S; Cohn, M; Efrati, S; Galperin, E; Modai, D; Rapoport, M; Weissgarten, J | 1 |
Agharazii, M; Larivière, R; Lebel, M; Rodrigue, ME | 1 |
Davies, RO; Gabriel, MA; Kramsch, DM; McFate Smith, W; Moncloa, F; Rush, JE; Walker, JF | 1 |
Bravo, EL; Fouad, FM; Tarazi, RC; Textor, SC | 1 |
Chrysant, SG; DeMasters, K; Dunn, M; Marples, D | 1 |
Cohn, JN; Levine, TB; Pierpont, GL | 1 |
Paradelis, AG; Paraskevopoulos, G; Pyrpasopoulos, M; Sion, M; Zuruzoglu, W | 1 |
Hricik, DE | 1 |
Barone-Varelas, J; Fried, W; Morley, C | 1 |
O'Connor, DT; Warren, SE | 1 |
Ardaillou, R; Benmansour, M; Caillens, H | 1 |
Cohen, EP; Fish, BL; Hill, P; Moulder, JE | 1 |
Iwamoto, Y; Iwasaki, N; Nanko, H; Wasada, T | 1 |
Farfel, Z; Kantor, R; Mayan, H | 1 |
Matsubara, M; Saito, T; Taguma, Y; Yoshinaga, K | 1 |
Bräunlich, H; Fleck, C; Sprott, H | 1 |
Hollenberg, NK | 1 |
Futaki, G; Ishizaki, M; Kitamoto, Y; Monma, H; Sasaki, Y; Sekino, H; Taguma, Y; Takahashi, H; Ueda, H | 1 |
2 review(s) available for captopril and Uremia
Article | Year |
---|---|
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.
Topics: Aged; Captopril; Humans; Hypertension; Male; Middle Aged; Proline; Renin; Uremia | 1983 |
The treatment of renovascular hypertension: surgery, angioplasty, and medical therapy with converting-enzyme inhibitors.
Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Captopril; Diuretics; Fibromuscular Dysplasia; Humans; Hypertension, Renovascular; Renal Artery; Risk; Uremia | 1987 |
2 trial(s) available for captopril and Uremia
Article | Year |
---|---|
Tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Drug Eruptions; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Leukocyte Count; Proteinuria; Taste; Uremia | 1984 |
Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Blood Coagulation; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Esters; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Protease Inhibitors; Proteinuria; Uremia | 1992 |
15 other study(ies) available for captopril and Uremia
Article | Year |
---|---|
Uremic conditions drive human monocytes to pro-atherogenic differentiation via an angiotensin-dependent mechanism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cell Adhesion; Cell Line; Cell Movement; Cell Proliferation; Humans; Lipopolysaccharides; Losartan; Monocytes; Peptidyl-Dipeptidase A; Uremia | 2014 |
Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Glomerular Filtration Rate; Hypertension, Renal; Irbesartan; Kidney; Kidney Failure, Chronic; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Survival Rate; Tetrazoles; Treatment Outcome; Uremia | 2005 |
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Kidney Failure, Chronic; Losartan; Nephrectomy; Rats; Rats, Wistar; Recombinant Proteins; Renin-Angiotensin System; Reserpine; Time Factors; Uremia | 2006 |
Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Glomerular Filtration Rate; Humans; Hyperkalemia; Hypertension, Renovascular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Proline; Renin; Uremia | 1982 |
Azotemia in patients with congestive heart failure treated with captopril.
Topics: Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Uremia | 1983 |
The effect of captopril on severe renin-dependent hypertension of uraemics on regular dialysis treatment.
Topics: Adult; Blood Pressure; Captopril; Humans; Hypertension, Renal; Male; Middle Aged; Proline; Renal Dialysis; Renin; Uremia | 1983 |
Reversible azotemia.
Topics: Captopril; Humans; Kidney Failure, Chronic; Proline; Renal Artery Obstruction; Uremia | 1983 |
Factors that regulate extrarenal erythropoietin production.
Topics: Angiotensin II; Animals; Captopril; Carbon Tetrachloride Poisoning; Colchicine; Erythropoiesis; Erythropoietin; Female; Indomethacin; Kinetics; Liver; Nephrectomy; Organ Specificity; Rats; Rats, Inbred Strains; Uremia | 1984 |
Hyperkalemia resulting from captopril administration.
Topics: Aldosterone; Captopril; Humans; Hyperkalemia; Hypertension; Hyponatremia; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Proline; Renin; Uremia | 1980 |
[The effect of inhibition of angiotensin II synthesis on the response of plasma antidiuretic hormone (ADH) to the osmotic and volume-dependent stimuli in uremic patients (author's transl)].
Topics: Adult; Aged; Angiotensin II; Blood; Captopril; Female; Humans; Male; Middle Aged; Osmolar Concentration; Sodium; Time Factors; Ultrafiltration; Uremia; Vasopressins | 1980 |
Prophylaxis of experimental bone marrow transplant nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Captopril; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enalapril; Kidney; Kidney Diseases; Male; Proteinuria; Radiation Injuries, Experimental; Rats; Time Factors; Uremia; Verapamil; Whole-Body Irradiation | 1994 |
Severe protracted lichenoid eruption and hyperuricemia following administration of alacepril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypertension; Lichenoid Eruptions; Uremia; Uric Acid | 1999 |
Trans-tubular potassium gradient in patients with drug-induced hyperkalemia.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Female; Humans; Hyperkalemia; Kidney Tubules; Male; Mineralocorticoid Receptor Antagonists; Potassium; Renal Insufficiency; Spironolactone; Uremia | 2001 |
Influence of vasoactive substances on uremic bleeding in rats.
Topics: 4-Aminobenzoic Acid; Angiotensin II; Animals; Bleeding Time; Blood Coagulation; Captopril; Chlorisondamine; Enalapril; Female; Fibronectins; Histamine; Nephrectomy; para-Aminobenzoates; Platelet Aggregation; Rats; Rats, Inbred Strains; Uremia; Ureteral Obstruction; Vasopressins | 1991 |
Effect of captopril on heavy proteinuria in azotemic diabetics.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Male; Middle Aged; Potassium; Proteinuria; Uremia | 1985 |